HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert L Hudkins Selected Research

Alzheimer Disease (Alzheimer's Disease)

1/2002Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert L Hudkins Research Topics

Disease

2Neoplasms (Cancer)
01/2012 - 12/2003
1Sleep Wake Disorders
01/2016
1Schizophrenia (Dementia Praecox)
01/2012
1Cognitive Dysfunction
07/2011
1Central Nervous System Diseases (CNS Diseases)
01/2010
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
02/2006
1Leukemia
02/2006
1Alzheimer Disease (Alzheimer's Disease)
01/2002
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2002

Drug/Important Bio-Agent (IBA)

26- (4- (3- (2- methylpyrrolidin- 1- yl)propoxy)phenyl)- 2H- pyridazin- 3- oneIBA
01/2012 - 07/2011
13- (1'- cyclobutylspiro(4H- 1,3- benzodioxine- 2,4'- piperidine)- 6- yl)- 5,5- dimethyl- 1,4- dihydropyridazin- 6- oneIBA
01/2016
1CytokinesIBA
01/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2012
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2012
1Antipsychotic Agents (Antipsychotics)IBA
01/2012
1Histamine (Histamine Dihydrochloride)FDA Link
07/2011
1Histamine H3 AntagonistsIBA
01/2010
1Proteins (Proteins, Gene)FDA Link
02/2006
1Anaplastic Lymphoma KinaseIBA
02/2006
1ProdrugsIBA
12/2003
1dimethylglycineIBA
12/2003
1compound 21IBA
12/2003
1EstersIBA
12/2003
1Transcription Factors (Transcription Factor)IBA
01/2002
1Phosphotransferases (Kinase)IBA
01/2002
13,9-bis((ethylthio)methyl)-K-252aIBA
01/2002

Therapy/Procedure

2Therapeutics
01/2012 - 01/2012